-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DYst83sZqbstWVGypWynUA1uF2EcOZ0HHRfHtxAnKMckYE7ONFBmp5CwTrRAAM7j lotWggASwWOyIdNRt8CpHA== 0001231977-04-000047.txt : 20041220 0001231977-04-000047.hdr.sgml : 20041220 20041220143423 ACCESSION NUMBER: 0001231977-04-000047 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041220 FILED AS OF DATE: 20041220 DATE AS OF CHANGE: 20041220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SQUINTO STEPHEN P CENTRAL INDEX KEY: 0001231954 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 041213761 MAIL ADDRESS: STREET 1: C/O ALEXION PHARMACEUTICALS INC STREET 2: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06410 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 BUSINESS PHONE: 2037761790 MAIL ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2004-12-20 0 0000899866 ALEXION PHARMACEUTICALS INC ALXN 0001231954 SQUINTO STEPHEN P C/O ALEXION PHARMACEUTICALS INC 352 KNOTTER DRIVE CHESHIRE CT 06410 0 1 0 0 EVP & Head of Research Common Stock, par value $.0001 2004-12-20 4 S 0 9000 25 D 17316 D Common Stock, par value $.0001 2004-12-20 4 S 0 540 25.241 D 16776 D Common Stock, par value $.0001 2004-12-20 4 S 0 400 25.24 D 16376 D Common Stock, par value $.0001 2004-12-20 4 S 0 100 25.23 D 16276 D Common Stock, par value $.0001 2004-12-20 4 S 0 1150 25.22 D 15126 D Common Stock, par value $.0001 2004-12-20 4 S 0 100 25.2 D 15026 D Common Stock, par value $.0001 2004-12-20 4 S 0 3150 25.15 D 11876 D The sales reported by this Form 4 are made pursuant to the terms of a Sales Plan designed to meet the requirements of Rule 10b5-1 (c) (1) of the Securities Exchange Act. /s/ Stephen P. Squinto 2004-12-20 -----END PRIVACY-ENHANCED MESSAGE-----